JenaValve Technology Raises $26.5M in Series C

What does JenaValve Technology do?

JenaValve Technology, is a developer, manufacturer and marketer of next gen transcatheter aortic valve repair systems for treating aortic valve disease. It develops transcatheter aortic valve implantation systems for transfemoral implantation and transapical implantation. Its technology offers customers the only TAVI Systems all over the world with CE approval for the treatment of aortic valve insufficiency and aortic valve stenosis. Their unique design and state of the art engineering has received international recognition and places the company to become one of the leaders in this top specialized medical device field. Its TAVI System received CE approval for treatment of aortic valve stenosis in 2011 September and the indication expansion for treating patients suffering from insufficiency of the aortic valve in September 2013.

How much JenaValve Technology was funded?

Jena Valve Technology raised $26.5M in Series C funding on August 7, 2015 from RMM (Lead), Edmond de Rothschild Investment Partners, Atlas Venture, Gimv, Neomed Management, Legend Capital, VI Partners and Valiance Solutions

Previous funding

• $13.5M in Venture round on March 15, 2010
• $62.5Min Series C funding on July 23, 2013 from Atlas Venture Partner: Peter Barrett, Gimv Partner: Patrick Van Beneden, Edmond de Rothschild Venture Capital Partner: Olivier Litzka, Neomed Management Partner: Erik Amble, Legend Capital Partner: Ouyang Xiangyu, Sunstone Capital, Omega Funds, VI Partners Partner: Arnd Kaltofen
• $10Min Series C on April 8, 2014 from Atlas Venture Partner: Peter Barrett, Legend Capital Partner: Ouyang Xiangyu, Gimv Partner: Patrick Van Beneden, Omega Funds, Neomed Management Partner: Erik Amble, RMM, Valiance Asset Management, Sunstone Capital and VI Partners Partner: Arnd  Kaltofen

What is next for JenaValve Technology?

JenaValve Technology’s latest funding will be used for supporting the Company’s further expansion in the global TAVR market. It helps the company with resources for delivering truly differentiated solutions for patients in need.

More about JenaValve Technology

JenaValve Technology was founded in 2006 by Hans-Reiner Figulla. It has its headquarters in München. At JenaValve, quality is very important, it is the main thing in tech development, device engineering and design process and this reflects the company’s German tradition.